A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body
Status:
Terminated
Trial end date:
2018-10-05
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to see how safe the investigational drug known as LY3009120
is and whether it will work to help people with advanced cancer or cancer that has spread to
other parts of the body.